Product ID: SQMIG35A2796
Global Sleep Apnea Implants Market Size, Share, Growth Analysis, By Product(Hypoglossal Neurostimulation Devices, Palatal Implants), By Indication(Central Sleep Apnea, Obstructive Sleep Apnea (OSA)) - Industry Forecast 2024-2031
Report ID:
SQMIG35A2796 |
Region:
Global |
Published Date: February, 2024
Pages:
219
|
Tables:
63 |
Figures:
75
Global Sleep Apnea Implants Market News
- In March 2023, Inspire Sleep, Inc. Introduced that it has acquired FDA approval for its Inspire 2 implantable top airway stimulation (UAIS) gadget for the treatment of obstructive sleep apnea (OSA). The Inspire 2 is a small, wireless device that is implanted in the chest and sends electric impulses to the tongue to keep it from collapsing at some stage in sleep.
- In April 2023, Somnomed announced that it has obtained CE Mark for its SomnoSure implantable UAIS device for the remedy of OSA. The SomnoSure is a similar tool to the Inspire 2, however it's far implanted inside the neck.
- In May 2023, The Cleveland Clinic announced that it has achieved the first successful implantation of the Inspire 2 in India. The affected person was a fifty five-12 months-vintage man with excessive OSA who had now not been able to tolerate other treatments.
- In June 2023, The University of Pennsylvania Sleep Center announced that it has opened a new health center dedicated to the treatment of OSA with implantable UAIS gadgets. The sanatorium is one of the few inside the u . S . That offers this sort of remedy.
Global Sleep Apnea Implants Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
